The synergistic role of CYP2E1 and CYP4A11 in the saturated and unsaturated fatty acids metabolism indicates their vital role in fasting, diabetes, and the progression of MASLD. Here, CYP2E1 is linked to metabolic dysfunction-associated steatotic liver disease.